Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Zolmitriptan (2.5mg) Tablet
Therapeutic Category
Neurology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Zoltrot 2.5 Tablet contains Zolmitriptan 2.5mg, a selective serotonin receptor agonist used for the acute treatment of migraine attacks, with or without aura. It helps relieve headache pain and associated symptoms such as nausea, sensitivity to light, and sound.
Zolmitriptan works by stimulating serotonin (5-HT1B/1D) receptors in the brain, leading to constriction of dilated cranial blood vessels and inhibition of pain signal transmission involved in migraine attacks.
This tablet is commonly prescribed for patients experiencing moderate to severe migraine episodes, providing rapid relief when taken at the onset of symptoms, under medical guidance.
Zoltrot 2.5 Tablet is valued for its fast onset of action, reliable symptom control, and consistent clinical effectiveness. Its role in acute migraine management makes it an important option in neurology-focused treatment protocols and headache care programs.
Common side effects may include dizziness, drowsiness, nausea, dry mouth, tingling sensation, and fatigue. Less common side effects include chest discomfort, palpitations, or blood pressure changes. Serious adverse effects are rare when used as prescribed.
Zoltrot 2.5 Tablet is indicated for the acute treatment of migraine with or without aura in adults. It helps reduce headache intensity along with associated symptoms such as nausea, vomiting, photophobia, and phonophobia.
Zoltrot 2.5 Tablet should be taken only under medical advice. It is not intended for migraine prevention or for treating other types of headaches. Use with caution in patients with cardiovascular risk factors, hypertension, or hepatic impairment. Do not exceed the recommended dose.
Store Zoltrot 2.5 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and use before the expiry date printed on the pack.
Composition : Danazol (100mg)
Composition : Danazol 200mg Capsule
Composition : Danazol (50mg)
Composition : Levofloxacin (250mg) + Ornidazole (500mg)
Composition : Ofloxacin (200mg) + Ornidazole (500mg)
Composition : Norfloxacin (400mg) + Tinidazole (600mg)
Composition : Faropenem (200mg)
Composition : Faropenem (200mg) + Clavulanic Acid (125mg)
Composition : Faropenem (300mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Zoltrot 2.5 Tablet has strong demand in the neurology and migraine treatment segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on CNS and pain-management portfolios.
Medical distributors and agencies can benefit from consistent demand for management of acute migraine attacks with or without aura. Zolmitriptan 2.5mg is a selective serotonin receptor agonist (triptan) that helps relieve migraine symptoms such as headache, nausea, and sensitivity to light/sound This strengthens a reliable neuro and pain-care prescription portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Zoltrot 2.5 Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from neurologist prescriptions, increasing migraine cases, fast-moving acute therapy demand, reliable supply chain support, and good margins in CNS and pain-management medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.